Noxopharm will make presentations at three investor conferences in the next six weeks:
26 February in Sydney (FNN-Shaw event at Radisson Blu Plaza Hotel, 1230 - 1430) - Greg van Wyk
26 March in Hong Kong - Graham Kelly
28 March in Shanghai - Graham Kelly
I attended the FNN event last year. Noxopharm was obviously the company that most interested me, but I was impressed by the potential of all presenting companies. It was certainly worthwhile making the effort to attend.
Greg van Wyk is an impressive speaker who will be able to provide context for the recent DARRT data. He might even discuss the implications of good results in the LuPIN trial. He is a strategic thinker, so it would not surprise if he also talks about the future direction for Noxopharm.
To attend, or to register for live streaming, go to: https://www.finnewsnetwork.com.au/page/investor-events
Upcoming Events
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $555 | 5.296K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 95000 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 151971 | 2 |
View Market Depth
| Last trade - 15.18pm 22/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
